Please select the outcome measures that correspond to the clinical trial below.
Title: Maxigesic IV Bunionectomy Study- A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group and Placebo-Controlled Study
Brief Summary: The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy


Options:
A: Summed Pain Intensity Difference (SPID)-Calculated From the Pain Intensity Scores Recorded on a 100mm Long Scale With Anchors for "no Pain" (0 mm) and "Worst Pain Imaginable" (100 mm). (48 hours after the first dose)
B: Pain Severity (Average pain score will be collected for preoperative visit (the day before surgery)); Pain Severity (Average pain score was collected for postoperative day 1); Pain Severity (Average pain score will be collected for postoperative day 2); Pain Severity (Average pain score will be collected for postoperative day 3); Pain Severity (Average pain score will be collected for postoperative day 4); Pain Severity (Average pain score will be collected for postoperative day 5); Pain Severity (Average pain score will be collected for postoperative day 6); Pain Severity (Average pain score will be collected for postoperative day 7); Medication Log (Postoperative day 1 to 7)
C: additional administration of analgesics (during stay time in PACU (postanesthesia care unit) average of over 30 minutes up to 1 hour)
D: Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 1:00 pm during the operative day]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 6:00 pm during the operative day]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 11:00 pm during the operative day]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 8:00 am during the 2th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 1:00 pm during the 2th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 6:00 pm during the 2th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 11:00 pm during the 2th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 8:00 am during the 3th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 1:00 pm during the 3th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 6:00 pm during the 3th day after surgery]); Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) (All study participants were asked to record the pain intensity score at 11:00 pm during the 3th day after surgery])

Answer: A